UK - A Cambridge-based life sciences venture capital group has closed its sixth fund on US$325m (£200m), nearly 30% of which came from pension fund investors.
Abingworth Management closed its Abingworth Bioventures IV above its original US$275m (£170m) target after additional interest in the fund shown by investors. Nearly a third of the funds raised ca...
To continue reading this article...
Join Professional Pensions
Become a Professional Pensions Lite Member today
In just a few clicks you can start your free Professional Pensions Lite membership for 12 months, providing you access to:
- Three complimentary articles per month covering the latest real-time news, analysis and opinion from the industry
- Receive important and breaking news stories via our two daily news alerts
- Hear from industry experts and other forward-thinking leaders
Are you a trustee, investment consultant or in-house pension and benefit scheme professional? You can apply for full complimentary access here
